{
  "main_header": {
    "sid": 197397,
    "name": "Syngene Intl.",
    "stock_name": "Syngene Intl.",
    "full_name": "Syngene International Ltd",
    "name_url": "stocks-analysis/syngene-intl",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "631.55",
    "chg": -10.85,
    "chgp": "-1.69%",
    "dir": -1,
    "prev_price": "642.40",
    "mcapval": "25,447.64 Cr",
    "mcap": "Small Cap",
    "scripcode": 539268,
    "symbol": "SYNGENE",
    "ind_name": "Healthcare Services",
    "ind_code": 4,
    "indexname": "",
    "isin": "INE398R01022",
    "curr_date": "Dec 05",
    "curr_time": "",
    "bse_nse_vol": "26.88 k",
    "exc_status": "Active",
    "traded_date": "Dec 05, 2025",
    "traded_date_str": "2025 12 05",
    "score": "",
    "scoreText": "",
    "Live": 1,
    "market_time": 1,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/syngene-intl-197397-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Is Syngene Intl. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-syngene-intl-technically-bullish-or-bearish-3747540",
        "imagepath": "",
        "date": "2025-12-05 08:17:41",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Technical Trend Overview</strong></p>\n<p>As of 04 Dec 2025, Syngene International's technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift suggests that while the stock is not in a strong downtrend, it has yet to establish a definitive bullish momentum. The change indicates a potential stabilisation phase, but caution remains warranted given the mixed signals from key technical indicators.</p>\n<p><strong>Key Technical Indicators: Weekly and Monthly Perspectives</strong></p>\n<p>Examining the Moving Average Convergence Divergence (MACD), the weekly chart shows a mildly bullish signal, hinting at some upward momentum in the short term. However, the monthly MACD remains bearish, reflecting longer-term caution. This divergence between weekly and mo..."
      },
      {
        "title": "Syngene International Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-technical-momentum-shifts-amid-bearish-outlook-3747479",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3747479.png",
        "date": "2025-12-05 08:01:18",
        "description": "Syngene International’s stock has exhibited a nuanced shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a predominantly bearish stance to a more mildly bearish outlook, with key indicators such as MACD and moving averages signalling subtle changes in price dynamics."
      },
      {
        "title": "Syngene International Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-downgraded-to-strong-sell-amid-weak-financials-and-bearish-technicals-3742904",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_mojoScore_3742904.png",
        "date": "2025-12-03 08:05:52",
        "description": "Syngene International, a key player in the healthcare services sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. This article analyses the recent changes in the company’s assessment across four critical parameters: quality, valuation, financial trend, and technicals."
      },
      {
        "title": "Syngene International Faces Bearish Momentum Amid Technical Shifts",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-faces-bearish-momentum-amid-technical-downturn-3742736",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3742736.png",
        "date": "2025-12-03 08:01:48",
        "description": "Syngene International, a key player in the Healthcare Services sector, is currently exhibiting a shift in its technical momentum, with several indicators signalling a bearish trend. The stock’s recent price movements and technical parameters suggest a cautious outlook as it navigates a challenging market environment."
      },
      {
        "title": "How has been the historical performance of Syngene Intl.?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/how-has-been-the-historical-performance-of-syngene-intl-3742196",
        "imagepath": "",
        "date": "2025-12-02 22:51:16",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n\n<p><strong>Revenue and Profit Growth</strong></p>\n<p>Syngene International’s net sales have shown consistent expansion, rising from ₹1,825.60 crores in March 2019 to ₹3,642.40 crores by March 2025. This represents a compound growth trend reflecting the company’s ability to scale its operations effectively. Correspondingly, total operating income mirrored this upward movement, with no other operating income reported during this period, indicating a primary reliance on core business activities.</p>\n<p>Operating profit before depreciation and interest (PBDIT) excluding other income increased from ₹536.80 crores in 2019 to ₹1,041.80 crores in 2025, underscoring improved operational efficiency. Including other income, operating profit rose to ₹1,113.60 crores in the latest fiscal year. Profit before tax als..."
      },
      {
        "title": "Syngene International Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-technical-momentum-shifts-amid-mixed-market-signals-3737420",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/12/SyngeneInternat_technicaldot_3737420.png",
        "date": "2025-12-01 08:00:32",
        "description": "Syngene International’s recent market activity reveals a nuanced shift in technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. The stock’s price movement and technical parameters suggest a transition from a predominantly bearish stance to a more cautiously optimistic outlook, warranting close attention from investors and market analysts alike."
      },
      {
        "title": "Syngene International Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-faces-bearish-momentum-amid-technical-indicator-shifts-3734559",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SyngeneInternat_technicaldot_3734559.png",
        "date": "2025-11-28 08:00:49",
        "description": "Syngene International, a key player in the healthcare services sector, is currently exhibiting a complex technical profile as recent evaluation adjustments reveal a shift in price momentum and mixed signals from key technical indicators. The stock’s performance contrasts with broader market trends, highlighting nuanced investor sentiment and technical dynamics."
      },
      {
        "title": "Syngene International’s Market Assessment Reflects Mixed Financial and Technical Signals",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/syngene-international-downgraded-to-sell-amid-mixed-technicals-and-weak-financials-3732408",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SyngeneInternat_mojoScore_3732408.png",
        "date": "2025-11-27 08:03:36",
        "description": "Syngene International, a key player in the healthcare services sector, has experienced a shift in market evaluation driven by a combination of financial performance, valuation metrics, and technical indicators. While the company’s recent quarterly results reveal challenges, evolving technical trends and valuation considerations have influenced the overall market perspective."
      },
      {
        "title": "Syngene International Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/syngene-international-technical-momentum-shifts-amid-mixed-market-signals-3732354",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/11/SyngeneInternat_technicaldot_3732354.png",
        "date": "2025-11-27 08:00:54",
        "description": "Syngene International’s recent technical assessment reveals a nuanced shift in price momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. While the stock shows signs of mild bullishness on weekly MACD indicators, other technical parameters suggest caution, underscoring a period of consolidation for this healthcare services company."
      }
    ],
    "total": 242,
    "sid": "197397",
    "stock_news_url": "https://www.marketsmojo.com/news/syngene-international-197397"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "02-Dec-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "27-Nov-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation",
      "datetime": "27-Nov-2025",
      "details": "Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please find the details of the meeting to be held with the Analyst/Institutional Investor.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has declared <strong>12%</strong> dividend, ex-date: 27 Jun 25",
          "dt": "2025-06-27",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Syngene International Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 11 Jun 19",
          "dt": "2019-06-11",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Is Syngene Intl. technically bullish or bearish?

2025-12-05 08:17:41

Technical Trend Overview

As of 04 Dec 2025, Syngene International's technical trend has transitioned from a clear bearish stance to a mildly bearish one. This subtle shift suggests that while the stock is not in a strong downtrend, it has yet to establish a definitive bullish momentum. The change indicates a potential stabilisation phase, but caution remains warranted given the mixed signals from key technical indicators.

Key Technical Indicators: Weekly and Monthly Perspectives

Examining the Moving Average Convergence Divergence (MACD), the weekly chart shows a mildly bullish signal, hinting at some upward momentum in the short term. However, the monthly MACD remains bearish, reflecting longer-term caution. This divergence between weekly and mo...

Read More

Syngene International Technical Momentum Shifts Amid Mixed Market Signals

2025-12-05 08:01:18

Syngene International’s stock has exhibited a nuanced shift in technical momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. Recent evaluation adjustments highlight a transition from a predominantly bearish stance to a more mildly bearish outlook, with key indicators such as MACD and moving averages signalling subtle changes in price dynamics.

Read More

Syngene International Faces Shift in Market Assessment Amidst Mixed Financial and Technical Signals

2025-12-03 08:05:52

Syngene International, a key player in the healthcare services sector, has experienced a notable shift in its market evaluation, reflecting a complex interplay of financial performance, valuation metrics, and technical indicators. This article analyses the recent changes in the company’s assessment across four critical parameters: quality, valuation, financial trend, and technicals.

Read More

Syngene International Faces Bearish Momentum Amid Technical Shifts

2025-12-03 08:01:48

Syngene International, a key player in the Healthcare Services sector, is currently exhibiting a shift in its technical momentum, with several indicators signalling a bearish trend. The stock’s recent price movements and technical parameters suggest a cautious outlook as it navigates a challenging market environment.

Read More

How has been the historical performance of Syngene Intl.?

2025-12-02 22:51:16

Revenue and Profit Growth

Syngene International’s net sales have shown consistent expansion, rising from ₹1,825.60 crores in March 2019 to ₹3,642.40 crores by March 2025. This represents a compound growth trend reflecting the company’s ability to scale its operations effectively. Correspondingly, total operating income mirrored this upward movement, with no other operating income reported during this period, indicating a primary reliance on core business activities.

Operating profit before depreciation and interest (PBDIT) excluding other income increased from ₹536.80 crores in 2019 to ₹1,041.80 crores in 2025, underscoring improved operational efficiency. Including other income, operating profit rose to ₹1,113.60 crores in the latest fiscal year. Profit before tax als...

Read More

Syngene International Technical Momentum Shifts Amid Mixed Market Signals

2025-12-01 08:00:32

Syngene International’s recent market activity reveals a nuanced shift in technical momentum, reflecting a complex interplay of bullish and bearish indicators across multiple timeframes. The stock’s price movement and technical parameters suggest a transition from a predominantly bearish stance to a more cautiously optimistic outlook, warranting close attention from investors and market analysts alike.

Read More

Syngene International Technical Momentum Shifts Amid Mixed Market Signals

2025-11-28 08:00:49

Syngene International, a key player in the healthcare services sector, is currently exhibiting a complex technical profile as recent evaluation adjustments reveal a shift in price momentum and mixed signals from key technical indicators. The stock’s performance contrasts with broader market trends, highlighting nuanced investor sentiment and technical dynamics.

Read More

Syngene International’s Market Assessment Reflects Mixed Financial and Technical Signals

2025-11-27 08:03:36

Syngene International, a key player in the healthcare services sector, has experienced a shift in market evaluation driven by a combination of financial performance, valuation metrics, and technical indicators. While the company’s recent quarterly results reveal challenges, evolving technical trends and valuation considerations have influenced the overall market perspective.

Read More

Syngene International Technical Momentum Shifts Amid Mixed Market Signals

2025-11-27 08:00:54

Syngene International’s recent technical assessment reveals a nuanced shift in price momentum, reflecting a complex interplay of bullish and bearish signals across multiple timeframes. While the stock shows signs of mild bullishness on weekly MACD indicators, other technical parameters suggest caution, underscoring a period of consolidation for this healthcare services company.

Read More

View All News